A.R.T. Advisors’s Kezar Life Sciences KZR Stock Holding History

A.R.T. Advisors’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,452	Closed	-$112K	–	1582
2019 Q2	$112K	Buy	+1,452	New	+$226K	0.01%	1179

Other funds holding KZR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

A.R.T. Advisors's KZR Position: Q3 2019 in Review

A.R.T. Advisors sold out of Kezar Life Sciences (KZR) in Q3 2019, closing a stake of 1,452 shares — an estimated $112K sold.

A.R.T. Advisors first reported a position in KZR in Q2 2019 and held it in 1 quarter. The position peaked at $112K in Q2 2019. 54 funds tracked by Wall St. Rank hold KZR as of Q3 2019.

A.R.T. Advisors reported no remaining Kezar Life Sciences position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 1,452 Kezar Life Sciences shares in Q3 2019, an estimated $112K.
A.R.T. Advisors first reported a position in Kezar Life Sciences in Q2 2019 and held it in 1 quarter.
A.R.T. Advisors's Kezar Life Sciences position peaked at $112K in Q2 2019.
54 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.